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N-Acetylcysteine has been used for treatment or prophylaxis of several distinct diseases that are associated with increased oxidative stress. 9 Th is thiolcontaining antioxidant was used to treat a variety of pulmonary diseases and to ameliorate the toxic eff ects in a variety of experimentally or clinically induced ischemia-reperfusion syndromes of the heart, kidney, and liver. 9 Furthermore, N-acetylcysteine causes vasodilatation in particular by enhancing the eff ects of nitric oxide, and it inhibits platelet aggregation. Because of its antioxidative properties, N-acetylcysteine therapy has been used in unstable angina, acute myocardial infarction, heart failure, hypertension, and paracetamol poisoning, and in critically ill patients with sepsis, although with variable results. Finally, N-acetylcysteine is oft en used to prevent contrast-induced nephropathy. However, at present there is limited evidence that acetylcysteine together with adequate hydration may be useful as standard prophylactic procedure in patients with a high risk for contrastinduced nephropathy. 10 Th e study by Feldman et al. 4 describes a novel application of N-acetylcysteine, which is cheap and without major side effects. If their results are confi rmed in additional studies, the oral administration of 600 mg N-acetylcysteine twice daily may help to prevent aminoglycoside-induced hearing loss in daily practice. Analogous recent literature suggests a relation between obesity and renal disease, and encourages weight loss, because this oft en leads to a reduction in proteinuria. 1,2 However, even though a lot of data suggest a linear relation between body mass index and proteinuria, the mechanisms involved remain elusive. Of course, most obese subjects do not develop renal disease. Hence, there must be other factors associated with obesity that lead to renal disease. Knowledge of these factors is important, because it will help us to counsel and treat overweight patients more effectively than simply recommending weight loss. Weight loss, although initially relatively easy, is hard to maintain. Even when maintained, weight loss might not always be the panacea that it is oft en considered to be.
Obese individuals oft en demonstrate hyperfiltration, 3 and angiotensinconverting enzyme inhibition is very eff ective in reducing their proteinuria. 1 Recently, drastic weight loss aft er bariatric surgery in morbidly obese patients commentar y induced parallel reductions in body mass index, glomerular filtration rate, and proteinuria. 4 Hence, hyperfi ltration has frequently been advanced as an underlying mechanism, 1 the assumption being that hyperfi ltration refl ects increased glomerular capillary pressure. However, classic single-nephron stop-fl ow pressure measurements in obese Zucker rats failed to document glomerular hypertension. 5 Moreover, a peroxisome proliferator-activated receptor-γ agonist, angiotensin-converting enzyme inhibition, and their combination markedly reduced proteinuria in this model without signifi cant reductions in glomerular fi ltration rate or glomerular capillary pressure. 6 Th us, although the discussion is by no means closed, nonhemodynamic mechanisms have been proposed. 2 Adipose tissue itself is a rich source of potential troublemakers. 2 Besides angiotensinogen and renin, it produces cytokines (tumor necrosis factor-α, interleukin-6), growth factors (plasminogen activator inhibitor-15, transforming growth factor-β), and the peptide hormone leptin. Leptin has many growthpromoting and proliferative eff ects in the kidney, and leptin infusion can induce glomerulosclerosis in rats. 2 Leptin resistance is common in obesity, resulting in high leptin levels that can increase sympathetic activity, which is known to be high in insulin resistance and obesity. However, extra-adipocyte leptin release, especially from the brain, is also increased in human obesity and may well contribute to the enhanced sympathetic drive. 7 In obese Zucker rats, renal injury can be ameliorated pharmacologically with a peroxisome proliferator-activated receptor-γ agonist, even though this intervention more than doubled body weight. 6 Th us, in some obese individuals, simply reducing weight in order to reduce adipose tissue may not be an adequate solution. A challenging study by Williams et al. 8 (this issue) now further questions the pathogenic role of increased blood pressure, hyperfi ltration, hyperleptinemia, hyperglycemia, and even obesity as such, in the pathogenesis of obesity-related renal injury. 8 As is mentioned above, there must be other factors that predispose some obese individuals to renal disease. One of these may be a disturbance in renal development. It is well known that symptoms of the metabolic syndrome are more severe in individuals who have been exposed to a perturbation during development, be it nutritional, environmental, pharmaceutical, or in the uteroplacental circulation. 9 Following up on previous studies, Williams et al. 8 exposed sheep dams to a 50% nutrient restriction from day 30 to day 80 of gestation (gestation in sheep lasts nearly 6 months), as compared with control dams who received a diet with an energy content of 7 megajoules per day. Th ereaft er all dams received a diet adjusted to 100% metabolizable energy until weaning of the lambs at 10 weeks of age. From weaning to 12 months of age, the lambs were either group-housed in a barn (restricted activity; 17 animals per 50 m 2 ) with ad libitum access to food to promote increased fat deposition (obese control (OC) group and obese prenatal nutrient-restricted (ONR) group) or pasture-grazed (unrestricted activity; 17 animals per 3,000 m 2 ) with ad libitum access to food (lean control (LC) group).
This setup allowed the authors to study the interaction of obesity and prenatal undernutrition, an unfortunate combination that is of growing importance in many parts of the world. 9 A strong methodological point is that obesity was induced by combination of restricted activity with ad libitum access to nutrients and that the degree of obesity was very similar in the OC and ONR groups. Th e hypothesis of the study was, of course, that the metabolic syndrome in general, and renal injury in particular, would be more severe in the ONR than in the OC group, because of, for instance, impaired nephrogenesis, and peripheral insulin resistance secondary to adiposity and leptin resistance. 9 However, as compared with the LC group, very similar increases were observed in blood pressure, heart rate, blood glucose, plasma leptin, glomerular fi ltration rate (determined by renography), and organ weights in both obese groups. Moreover -and this is the salient and unexpected fi nding -glomerular injury and apoptosis in both renal cortex and medulla were much more pronounced in the OC than in the ONR or LC group. Unfortunately, pasture-grazed lean prenatal nutrient-restricted sheep were not studied, although some data available from previous experiments indicate that this combination did not have any signifi cant eff ects in the kidney.
Th e explanation for these unexpected fi ndings is not known. Interestingly, only the OC group showed enhanced mRNA Hans Bouwer commentar y expression of glucocorticoid and angiotensin II receptors and tumor necrosis factor-α, but this could all be secondary to renal injury. Accumulation of extracellular matrix within the kidney may also play a role, as obesity has been shown to induce accumulation of hyaluronan in the renal medulla of dogs and rabbits. External compression of the kidney by visceral fat may increase interstitial hydrostatic pressure or induce ischemia. Such physical changes could also enhance sympathetic activity in obesity. 10 Apparently, sheep and other ungulates have adapted to pregnancy in winter when conditions are harsh and nutrients scarce. At high altitudes, nutrient restriction and a harsh climate are compounded by hypoxia (Figure 1 ). One aspect of this adaptation is undoubtedly the building up of reserves in the summer in combination with a lot of movement all year round. A surfeit of nutrients during intrauterine life apparently interferes with this cycle and caused these sheep to lose some unknown protective factor, the resulting injury subsequently being triggered by obesity. However, in our opinion, this peculiar ovine maladjustment is not the most important point of the study.
What is of importance is that, during evolution, matching of perinatal, juvenile, and adult conditions has apparently been a powerful selective force. 11 Because nowadays life expectancy exceeds our reproductive age and modern lifestyle includes excessive calorie and sodium intake, a mismatch of these conditions is increasingly apparent and can enhance susceptibility to a host of diseases. 9, 11 Th e observations by Williams et al. 8 stress that with today's knowledge it remains hard to predict the outcome of a specifi c developmental perturbation. Clearly, the mechanisms remain shrouded but may well include metabolic eff ects on genetic imprinting that cause persistent eff ects long aft er early development.
